GETI.B

192.05

-0.36%↓

CAMX

655.5

-3.03%↓

VITR

137

-1.23%↓

ATT

68.8

-1.01%↓

ARJOB

33.12

-0.9%↓

GETI.B

192.05

-0.36%↓

CAMX

655.5

-3.03%↓

VITR

137

-1.23%↓

ATT

68.8

-1.01%↓

ARJOB

33.12

-0.9%↓

GETI.B

192.05

-0.36%↓

CAMX

655.5

-3.03%↓

VITR

137

-1.23%↓

ATT

68.8

-1.01%↓

ARJOB

33.12

-0.9%↓

GETI.B

192.05

-0.36%↓

CAMX

655.5

-3.03%↓

VITR

137

-1.23%↓

ATT

68.8

-1.01%↓

ARJOB

33.12

-0.9%↓

GETI.B

192.05

-0.36%↓

CAMX

655.5

-3.03%↓

VITR

137

-1.23%↓

ATT

68.8

-1.01%↓

ARJOB

33.12

-0.9%↓

Search

RaySearch Laboratories AB

Отворен

307 -3.31

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

306

Максимум

318

Ключови измерители

By Trading Economics

Приходи

-6.4M

71M

Продажби

9M

332M

P/E

Средно за сектора

51.03

40.048

EPS

1.66

Дивидентна доходност

0.93

Марж на печалбата

21.41

Служители

422

EBITDA

1.2M

75M

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

0.93%

2.45%

Следващи печалби

8.08.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

770M

11B

Предишно отваряне

310.31

Предишно затваряне

307

RaySearch Laboratories AB Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

5.08.2025 г., 23:11 ч. UTC

Печалби

Australia's REA Hikes Dividend as Annual Profit Rises 23% -- Update

5.08.2025 г., 22:45 ч. UTC

Печалби

Australia's REA Hikes Dividend as Annual Profit Rises 23%

5.08.2025 г., 22:39 ч. UTC

Печалби

Great-West Lifeco Logs Lower 2Q Profit

5.08.2025 г., 21:32 ч. UTC

Печалби

Coupang Posts Higher 2Q Sales Due to Customer Growth

6.08.2025 г., 00:00 ч. UTC

Придобивния, сливания и поглъщания

NFL to Take 10% Stake in Disney's ESPN -- WSJ

6.08.2025 г., 00:00 ч. UTC

Придобивния, сливания и поглъщания

The NFL Is Taking a 10% Stake in Disney's ESPN -- WSJ

6.08.2025 г., 00:00 ч. UTC

Придобивния, сливания и поглъщания

Disney to Take Control of NFL Network as Part of Agreement -- WSJ

6.08.2025 г., 00:00 ч. UTC

Придобивния, сливания и поглъщания

Disney, NFL Strike Wide-Reaching Media-Asset Deal -- WSJ

5.08.2025 г., 23:48 ч. UTC

Пазарно говорене

Nikkei May Decline Amid U.S. Economic Uncertainty -- Market Talk

5.08.2025 г., 23:40 ч. UTC

Пазарно говорене

Gold Edges Higher, Supported by Fed Rate-Cut Hopes -- Market Talk

5.08.2025 г., 23:19 ч. UTC

Пазарно говорене

Lindian Deal With Iluka Demonstrates Kangankunde Project Appeal -- Market Talk

5.08.2025 г., 23:03 ч. UTC

Пазарно говорене
Печалби

Advanced Micro Devices' Data-Center Story Seen as Promising -- Market Talk

5.08.2025 г., 22:22 ч. UTC

Печалби

REA: Expectation of More Interest-Rate Cuts Likely to Support Buyer Demand>REA.AU

5.08.2025 г., 22:21 ч. UTC

Печалби

REA Expects FY26 Listing Volumes Broadly Flat on FY25>REA.AU

5.08.2025 г., 22:20 ч. UTC

Печалби

REA Expects September-Quarter Listings to Be Down on Year>REA.AU

5.08.2025 г., 22:18 ч. UTC

Печалби

REA July 2025 New Residential Listings Down 8% on Year>REA.AU

5.08.2025 г., 22:17 ч. UTC

Печалби

REA FY25 Australian Residential Listings Up 1% on Year>REA.AU

5.08.2025 г., 22:17 ч. UTC

Печалби

REA FY25 India Revenue A$129M Vs. A$103M>REA.AU

5.08.2025 г., 22:16 ч. UTC

Печалби

REA FY25 Core Australia Revenue A$1.54B Vs. A$1.35B>REA.AU

5.08.2025 г., 22:16 ч. UTC

Печалби

REA FY25 Core Operations Net Profit A$564.4M Vs. A$460.5M>REA.AU

5.08.2025 г., 22:15 ч. UTC

Печалби

REA Group FY25 Ebitda A$969.2M Vs. A$824.8M>REA.AU

5.08.2025 г., 22:13 ч. UTC

Печалби

REA Group Raises Dividend to A$1.38 Vs. A$1.02 >REA.AU

5.08.2025 г., 22:13 ч. UTC

Печалби

REA Group FY25 Rev A$1.67B Vs. A$1.45B >REA.AU

5.08.2025 г., 22:12 ч. UTC

Печалби

REA FY25 Core Operations Net Profit A$564.4M Vs, A$460.5M>REA.AU

5.08.2025 г., 22:12 ч. UTC

Печалби

REA Group FY25 Net A$677.9M Vs. Net A$302.8M >REA.AU

5.08.2025 г., 21:58 ч. UTC

Печалби

Novo Nordisk's Earnings Come After a Dramatic Guidance Cut. What to Look for Now. -- Barrons.com

5.08.2025 г., 21:30 ч. UTC

Печалби

AMD Gives a Strong Outlook. Why the Stock Is Falling. -- Barrons.com

5.08.2025 г., 21:26 ч. UTC

Печалби

AMD CEO Expects Embedded Segment to Return to Sequential Growth in Back Half of 2025

5.08.2025 г., 21:23 ч. UTC

Печалби

AMD CEO Sees Strong Customer Interest in MI400 Series for Large-Scale Deployments

5.08.2025 г., 21:17 ч. UTC

Печалби

AMD Expects Steep Production Ramp for MI350 Series in Back Half of Year, CEO Says

Сравнение с други в отрасъла

Ценова промяна

RaySearch Laboratories AB Прогноза

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. It develops and markets RayStation, a treatment planning system for radiation therapy; RayCare, an oncology information system that manages clinical activities; RayIntelligence, a cloud-based analytics system for monitoring and enhancement of cancer therapy; and RayCommand, a treatment control system that serves as link between the treatment machine and the treatment planning and oncology information systems. The company offers RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, and electron beam radiation therapy; and µ-RayStation, a software platform for planning and evaluation in small animal irradiation research. The company (publ) is headquartered in Stockholm, Sweden.